Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dersalazine, a PAF antagonist and TNFα inhibitor, is used potentially for the treatment of ulcerative colitis. It showed anti-inflammatory effect in reactivated colitis in rats, as evidenced by a significant reduction in MPO activity.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 486,500 |
50 mg | 約8-10 週間 | ¥ 638,000 |
100 mg | 約8-10 週間 | ¥ 849,500 |
説明 | Dersalazine, a PAF antagonist and TNFα inhibitor, is used potentially for the treatment of ulcerative colitis. It showed anti-inflammatory effect in reactivated colitis in rats, as evidenced by a significant reduction in MPO activity. |
別名 | UR12746, Dersalazine, UR 12746S (sodium salt), UR-12746S (sodium salt), UR-12746 |
分子量 | 623.669 |
分子式 | C35H32N6NaO4 |
CAS No. | 367249-56-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dersalazine sodium 367249-56-7 UR12746 UR 12746 Dersalazine UR 12746S (sodium salt) UR 12746S UR-12746S UR-12746S (sodium salt) UR-12746 Inhibitor inhibitor inhibit